Pelargonium Extract EPs 7630 in the Treatment of Human Corona Virus-Associated Acute Respiratory Tract Infections – A Secondary Subgroup-Analysis of an Open-Label, Uncontrolled Clinical Trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pelargonium Extract EPs 7630 in the Treatment of Human Corona Virus-Associated Acute Respiratory Tract Infections – A Secondary Subgroup-Analysis of an Open-Label, Uncontrolled Clinical Trial
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-04-30
DOI
10.3389/fphar.2021.666546
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Influence of EPs 7630 on Antipyretic Comedication and Recovery from Acute Tonsillopharyngitis in Children: A Meta-analysis of Randomized, Placebo-Controlled, Clinical Trials
- (2021) Georg Seifert et al. Journal of Pediatric Infectious Diseases
- Recent discovery and development of inhibitors targeting coronaviruses
- (2020) Thanigaimalai Pillaiyar et al. DRUG DISCOVERY TODAY
- The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
- (2020) Hussin A. Rothan et al. JOURNAL OF AUTOIMMUNITY
- Phytotherapic compounds against coronaviruses: Possible streams for future research
- (2020) Michele Antonelli et al. PHYTOTHERAPY RESEARCH
- Challenges at the Time of COVID-19: Opportunities and Innovations in Antivirals from Nature
- (2020) Andreas Hensel et al. PLANTA MEDICA
- Natural product-derived phytochemicals as potential agents against coronaviruses: A review
- (2020) Janice S. Mani et al. VIRUS RESEARCH
- The herbal extract EPs® 7630 increases the antimicrobial airway defense through monocyte-dependent induction of IL-22 in T cells
- (2020) Katrin Witte et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy?
- (2020) Dâmaris Silveira et al. Frontiers in Pharmacology
- Botanical drugs and supplements affecting the immune response in the time of COVID ‐19: Implications for research and clinical practice
- (2020) Thomas Brendler et al. PHYTOTHERAPY RESEARCH
- Pelargonium sidoides radix extract EPs 7630 reduces rhinovirus infection through modulation of viral binding proteins on human bronchial epithelial cells
- (2019) Michael Roth et al. PLoS One
- Faster recovery and reduced paracetamol use – a meta-analysis of EPs 7630 in children with acute respiratory tract infections
- (2019) Georg Seifert et al. BMC Pediatrics
- Complementary and alternative medicine in the treatment of acute bronchitis in children: A systematic review
- (2019) P.M. Wopker et al. COMPLEMENTARY THERAPIES IN MEDICINE
- A new class of hepatitis B and D virus entry inhibitors, proanthocyanidin and its analogs, that directly act on the viral large surface proteins
- (2017) Senko Tsukuda et al. HEPATOLOGY
- Grape Seed Proanthocyanidin Inhibits Mucin Synthesis and Viral Replication by Suppression of AP-1 and NF-κB via p38 MAPKs/JNK Signaling Pathways in Respiratory Syncytial Virus-Infected A549 Cells
- (2017) Jin-Woo Lee et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Different Inhibitory Potencies of Oseltamivir Carboxylate, Zanamivir, and Several Tannins on Bacterial and Viral Neuraminidases as Assessed in a Cell-Free Fluorescence-Based Enzyme Inhibition Assay
- (2017) Stefanie Quosdorf et al. MOLECULES
- Coronavirus and Other Respiratory Illnesses Comparing Older with Young Adults
- (2015) Geoffrey J. Gorse et al. AMERICAN JOURNAL OF MEDICINE
- The Pelargonium sidoides Extract EPs 7630 Drives the Innate Immune Defense by Activating Selected MAP Kinase Pathways in Human Monocytes
- (2015) Katrin Witte et al. PLoS One
- Medicinal properties and conservation of Pelargonium sidoides DC.
- (2014) Mack Moyo et al. JOURNAL OF ETHNOPHARMACOLOGY
- The Root Extract of the Medicinal Plant Pelargonium sidoides Is a Potent HIV-1 Attachment Inhibitor
- (2014) Markus Helfer et al. PLoS One
- 3-O-Galloylated Procyanidins from Rumex acetosa L. Inhibit the Attachment of Influenza A Virus
- (2014) Andrea Derksen et al. PLoS One
- EPs® 7630 (Umckaloabo®), an extract from Pelargonium sidoides roots, exerts anti-influenza virus activity in vitro and in vivo
- (2012) Linda L. Theisen et al. ANTIVIRAL RESEARCH
- Can the Pelargonium sidoides root extract EPs® 7630 prevent asthma attacks during viral infections of the upper respiratory tract in children?
- (2012) Fulya Tahan et al. PHYTOMEDICINE
- Immune responses induced by Pelargonium sidoides extract in serum and nasal mucosa of athletes after exhaustive exercise: Modulation of secretory IgA, IL-6 and IL-15
- (2010) L.A. Luna et al. PHYTOMEDICINE
- Investigation of the influence of EPs® 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses
- (2010) Martin Michaelis et al. PHYTOMEDICINE
- Human Coronavirus and Acute Respiratory Illness in Older Adults with Chronic Obstructive Pulmonary Disease
- (2009) Geoffrey J. Gorse et al. JOURNAL OF INFECTIOUS DISEASES
- Pelargonium sidoides for acute bronchitis: A systematic review and meta-analysis
- (2008) Taofikat B. Agbabiaka et al. PHYTOMEDICINE
- A Detailed View on the Constituents of EPs® 7630
- (2008) Karl Schoetz et al. PLANTA MEDICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation